WO2014090223A3 - Zusammensetzungen und lösungen für die darmreinigung - Google Patents
Zusammensetzungen und lösungen für die darmreinigung Download PDFInfo
- Publication number
- WO2014090223A3 WO2014090223A3 PCT/DE2013/000790 DE2013000790W WO2014090223A3 WO 2014090223 A3 WO2014090223 A3 WO 2014090223A3 DE 2013000790 W DE2013000790 W DE 2013000790W WO 2014090223 A3 WO2014090223 A3 WO 2014090223A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- solutions
- compositions
- colon cleansing
- defoaming
- agents
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
- A61K31/77—Polymers containing oxygen of oxiranes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/10—Carbonates; Bicarbonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/485—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Detergent Compositions (AREA)
Abstract
Polysiloxane sind als Entschäumer unter anderem in medizinischen Zusammensetzungen wie Darmspüllösungen und Antiflatulantien enthalten. Ziel war es, die entschäumende Wirkung der Polysiloxane und damit die Verträglichkeit der Mittel insgesamt weiter zu verbessern. Wie gefunden wurde, verstärkt Calciumsulfat die entschäumende Wirkung von Dimeticon oder Simeticon als Polysiloxan-Entschäumer. Die Erfindung offenbart PEG-haltige Darmspüllösungen auf dieser Basis.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP13830175.9A EP2931258B1 (de) | 2012-12-14 | 2013-12-12 | Zusammensetzungen und lösungen für die darmreinigung |
US14/651,020 US10617761B2 (en) | 2012-12-14 | 2013-12-12 | Compositions and solutions for colon cleansing |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102012024434.7 | 2012-12-14 | ||
DE102012024434.7A DE102012024434A1 (de) | 2012-12-14 | 2012-12-14 | Verstärkung der entschäumenden Wirkung von Polysiloxanen, zugehöriger Zusammensetzungen und Lösungen |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2014090223A2 WO2014090223A2 (de) | 2014-06-19 |
WO2014090223A3 true WO2014090223A3 (de) | 2014-10-09 |
Family
ID=50137452
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/DE2013/000790 WO2014090223A2 (de) | 2012-12-14 | 2013-12-12 | Zusammensetzungen und lösungen für die darmreinigung |
Country Status (4)
Country | Link |
---|---|
US (1) | US10617761B2 (de) |
EP (1) | EP2931258B1 (de) |
DE (1) | DE102012024434A1 (de) |
WO (1) | WO2014090223A2 (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102173069B1 (ko) * | 2016-03-22 | 2020-11-02 | 가부시키가이샤 지씨 | 치과용 알긴산염 인상재 |
US11147824B1 (en) | 2016-10-11 | 2021-10-19 | New York University | Colonic irrigation composition |
EP4199900A1 (de) * | 2020-08-20 | 2023-06-28 | Biofarma S.r.l. | Zusammensetzung und formulierung zur behandlung von obstipation und bauchbloration |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006094737A2 (en) * | 2005-03-07 | 2006-09-14 | Alfa Wassermann S.P.A. | Gastroresistant pharmaceutical formulations containing rifaximin |
WO2006134492A2 (en) * | 2005-04-12 | 2006-12-21 | Agi Therapeutics Research Limited | Acarbose methods and formulations for treating chronic constipation |
DE102006001199A1 (de) * | 2006-01-10 | 2007-07-12 | Medicoforum Gmbh | Fixe Kombination von Substanzen unter Beigabe von Entschäumern zum Einsatz als Darmspüllösung und/oder Laxans |
US20080038336A1 (en) * | 2006-08-10 | 2008-02-14 | Marta Luz Torres Esquea | Solid pharmaceutical composition containing a combination of an intestinal motility regulating agent and an antiflatulent |
WO2009036906A1 (de) * | 2007-09-22 | 2009-03-26 | Bayer Consumer Care Ag | Zusammensetzung mit wirkstoffkombination aus einem laxans und einem entschäumer zur behandlung von obstipation |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3501571A (en) * | 1965-12-06 | 1970-03-17 | Smithkline Corp | Novel silicone compositions and method of preparing same |
US4582709A (en) * | 1985-02-08 | 1986-04-15 | Warner-Lambert Company | Chewable mineral supplement |
DE3807712A1 (de) | 1987-07-25 | 1989-02-02 | Nordend Apotheke Angela Hein | Arzneimittel-trockenpraeparat zur bereitung einer laxativ wirkenden trinkloesung sowie ein verfahren zur herstellung dieses praeparates |
HU203477B (en) | 1989-10-26 | 1991-08-28 | Janos Plachy | Process for producing antiflatulant pharmaceutical compositions containing activated poly-dimethyl-siloxane in form of solide dispersion |
DE4341165C1 (de) | 1993-12-02 | 1995-04-20 | Upmeyer Hans Juergen | Verwendung von Dimeticon zur Behandlung von Obstipation |
JPH10176199A (ja) * | 1996-12-18 | 1998-06-30 | Lion Corp | 粒状消泡剤組成物および粒状洗剤組成物 |
GB0224909D0 (en) * | 2002-10-25 | 2002-12-04 | Norgine Europe Bv | Colon cleansing compositions |
WO2004078182A1 (fr) | 2003-02-05 | 2004-09-16 | Jean-Luc Derre | Medicament ou alicament associant un saccharide soluble mal absorbe et un antiflatulent de la famille des siloxanes |
CA2432358A1 (en) * | 2003-06-13 | 2004-12-13 | Medical Futures Inc. | Nutritional supplementation for treating deficiency states in bowel disease |
JP2008503445A (ja) | 2004-04-13 | 2008-02-07 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 便秘患者におけるシメチコンの使用 |
US20050244368A1 (en) | 2004-04-29 | 2005-11-03 | Pashankar Dinesh S | Pre-endoscopic use of polyethylene glycol compositions |
WO2007057924A1 (en) * | 2005-11-21 | 2007-05-24 | Panacea Biotec Ltd | Laxative composition on the basis of triphala |
WO2009052256A2 (en) * | 2007-10-17 | 2009-04-23 | Thomas Jefferson University | Bowel purgative and uses thereof |
-
2012
- 2012-12-14 DE DE102012024434.7A patent/DE102012024434A1/de not_active Withdrawn
-
2013
- 2013-12-12 WO PCT/DE2013/000790 patent/WO2014090223A2/de active Application Filing
- 2013-12-12 US US14/651,020 patent/US10617761B2/en active Active
- 2013-12-12 EP EP13830175.9A patent/EP2931258B1/de active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006094737A2 (en) * | 2005-03-07 | 2006-09-14 | Alfa Wassermann S.P.A. | Gastroresistant pharmaceutical formulations containing rifaximin |
WO2006134492A2 (en) * | 2005-04-12 | 2006-12-21 | Agi Therapeutics Research Limited | Acarbose methods and formulations for treating chronic constipation |
DE102006001199A1 (de) * | 2006-01-10 | 2007-07-12 | Medicoforum Gmbh | Fixe Kombination von Substanzen unter Beigabe von Entschäumern zum Einsatz als Darmspüllösung und/oder Laxans |
US20080038336A1 (en) * | 2006-08-10 | 2008-02-14 | Marta Luz Torres Esquea | Solid pharmaceutical composition containing a combination of an intestinal motility regulating agent and an antiflatulent |
WO2009036906A1 (de) * | 2007-09-22 | 2009-03-26 | Bayer Consumer Care Ag | Zusammensetzung mit wirkstoffkombination aus einem laxans und einem entschäumer zur behandlung von obstipation |
Also Published As
Publication number | Publication date |
---|---|
US20150320793A1 (en) | 2015-11-12 |
EP2931258A2 (de) | 2015-10-21 |
US10617761B2 (en) | 2020-04-14 |
DE102012024434A1 (de) | 2014-06-18 |
WO2014090223A2 (de) | 2014-06-19 |
EP2931258B1 (de) | 2019-09-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2018016021A (es) | Composiciones y metodos que comprenden variante de enzima lipolitica. | |
EA201291125A1 (ru) | Композиции глины | |
HK1212165A1 (en) | Nutritional compositions including calcium beta-hydroxy-beta- methylbutyrate, protein and low levels of electrolytes --- | |
MX362655B (es) | Composiciones cosmeticas. | |
BR112012032028A2 (pt) | compostos de tioacetato, composições e métodos de uso. | |
WO2012027073A8 (en) | Saccharide siloxanes stable in aqueous environments and methods for the preparation and use of such saccharide siloxanes | |
IL236655A0 (en) | Microporous zirconium silicate for the treatment of hyperkalemia in hypercalcemic patients and improved preparations containing calcium for the treatment of hyperkalemia | |
MX353597B (es) | Composición para el cuidado oral que contiene líquidos iónicos. | |
MX352814B (es) | Composiciones para el cuidado oral que comprenden carbonato de calcio y talco. | |
PH12016500495A1 (en) | Compositions for the treatment of hypertension and/or fibrosis | |
WO2014090223A3 (de) | Zusammensetzungen und lösungen für die darmreinigung | |
IN2014DN07326A (de) | ||
EP2814491A4 (de) | Formulierungen und verfahren zur behandlung oder prophylaxe von prä-mci und/oder prä-alzheimer-erkrankungen | |
FR2961402B1 (fr) | Compositions contenant des arabinoxylo-oligosaccharides et leurs utilisations | |
EP2249843A4 (de) | Verwendung immunogener zusammensetzungen für die behandlung oder prävention von infektionen durch krankheitserreger | |
MX2015001648A (es) | Composiciones que comprenden derivados de espicamicina y metodos de uso de los mismos. | |
WO2010104281A3 (ko) | 아토피성 피부질환 개선용 조성물 | |
MX2015007226A (es) | Mejoramiento de la eficacia esporicida de composiciones de alcohol y peroxido. | |
FR2992219B1 (fr) | Composition pour le traitement de l'hypocalcemie chez les ruminants | |
EA201591521A1 (ru) | Композиция, содержащая арабиногалактан и полифенолы из лиственницы | |
MX2016002714A (es) | Composicion y metodo para tropicalizar chocolate. | |
IN2015MN00091A (de) | ||
WO2013117375A3 (de) | Zusammensetzung enthaltend hydroxyethylcellulose | |
EA201492173A1 (ru) | Дронедарон для применения при лейшманиозе, в составах и комбинациях для применения при лейшманиозе | |
EA201401059A1 (ru) | Композиция кускового мыла |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 13830175 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 14651020 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2013830175 Country of ref document: EP |